Although APOC2 is a critical factor for LPL activity and APOA5 stabilized LPL‐APOC2 complex, the reports of circulating levels of APOC2 and APOA5 as biomarkers in patients with type 2 diabetes are scarce. This evidence concerns the gene APOC2 and type 2 diabetes mellitus.